IMR Press / EJGO / Volume 26 / Issue 4 / pii/2005205

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Case Report

Adenosquarnous carcinoma of the uterine cervix - adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report

Show Less
1 Merkur University Hospital, Zagreb (Croatia)
Eur. J. Gynaecol. Oncol. 2005, 26(4), 449–450;
Published: 10 August 2005

Adenosquamous carcinoma of the uterine cervix is a rare mixture of malignant glandular and squamous epithelial elements. We present a case of a 56-year-old woman with Stage IV cervical carcinoma treated with paclitaxel and carboplatin chemotherapy after cytoreductive surgery. Solitary liver metastases were treated by ultrasound guided percutaneous sclerotherapy with 95% ethanol. For ten months the patient showed an objective response to the treatment with a good quality of life during that time. A year after the first, the second cytoreductive operation was performed and chemotherapy (paclitaxel, carboplatin, and epiru­bicin) followed. The patient died 20 months after establishing the diagnosis. Paclitaxel in combination with carboplatin as adjuvant chemotherapeutic treatment could be another promising agent for patients with advanced metastatic cervical adenocarcinoma.

Cervical adenosquamous cancer
Adjuvant chemotherapy
Back to top